Diagnostic Approach for Elevated Eosinophils
When eosinophil levels are elevated, a systematic diagnostic workup should be performed starting with comprehensive laboratory testing to identify the underlying cause, followed by targeted testing for specific conditions based on initial findings.
Initial Evaluation
- Obtain a complete blood count with differential to confirm eosinophilia and assess for other blood count abnormalities (dysplasia, monocytosis, circulating blasts) 1
- Perform routine serum chemistries including liver function tests, lactate dehydrogenase, and uric acid 1
- Check vitamin B12 levels, as they may be elevated in myeloproliferative variants 2
- Measure serum immunoglobulin levels (IgG, IgA, IgM, IgE) as there may be an inverse relationship between IgE levels and blood eosinophil counts in certain conditions 1, 2
- Order inflammatory markers such as C-reactive protein and erythrocyte sedimentation rate 1
- Perform urinalysis and assess for proteinuria (24-hour collection or protein-to-creatinine ratio) 1
Classification-Based Approach
For Mild Eosinophilia (500-1500 cells/μL)
- Evaluate for common causes such as allergies, atopy, drug reactions, and autoimmune disorders 1, 3
- Review medication history for potential drug reactions 4
- Consider parasitic infection screening, especially with relevant travel history 4, 5
For Hypereosinophilia (≥1500 cells/μL)
- Refer to hematology for further investigation, especially if persistent for more than 3 months 1, 6
- Assess for symptoms of organ damage (cardiac, pulmonary, neurologic, gastrointestinal) 1, 7
- Evaluate for hypereosinophilic syndrome (HES) using criteria from Table 2 classification 7
Advanced Testing Based on Initial Findings
For Suspected Secondary (Reactive) Causes
- Perform serology testing for parasitic infections, particularly Strongyloides 1, 2
- Order stool examination for ova and parasites if gastrointestinal symptoms are present 1, 4
- Test for autoimmune markers (ANA, ANCA) if autoimmune disease is suspected 1, 4
- Consider allergic bronchopulmonary aspergillosis testing (Aspergillus IgE) 2
For Suspected Primary (Neoplastic) Causes
- Perform bone marrow aspirate and biopsy with immunohistochemistry 2
- Order conventional cytogenetics 2
- Conduct fluorescence in situ hybridization (FISH) and/or nested RT-PCR to detect tyrosine kinase fusion gene rearrangements (PDGFRA, PDGFRB, FGFR1, JAK2) 7, 2
- Consider next-generation sequencing via myeloid mutation panels to establish clonality 2
- Test for KIT D816V mutation, which occurs in most patients with systemic mastocytosis 2
For Suspected Lymphocytic Variant HES
- Perform flow cytometry to identify aberrant T-cell populations 2
- Consider molecular analysis to confirm T-cell clonality when flow cytometry results are equivocal 2
Organ-Specific Evaluation
- Echocardiography and/or cardiac MRI if cardiac involvement is suspected 7
- Pulmonary function tests and chest imaging for suspected respiratory involvement 1
- Endoscopy with biopsies for suspected gastrointestinal involvement 7
- Skin biopsy for cutaneous manifestations 7
- Neurological evaluation including imaging for suspected nervous system involvement 7
Common Pitfalls to Avoid
- Failing to evaluate for parasitic infections in patients with relevant travel history 4, 5
- Not recognizing that normal IgE levels with elevated eosinophils may suggest non-allergic causes 4
- Overlooking potential organ damage in patients with persistent eosinophilia 1, 6
- Not testing for specific genetic abnormalities that may predict response to targeted therapies 1, 7
- Premature closure of diagnosis without comprehensive genetic testing, as rare mutations may be present 2
When to Refer to Specialists
- Eosinophilia ≥1500 cells/μL persisting for more than 3 months requires hematology evaluation 1, 6
- Any evidence of end-organ damage potentially related to eosinophilia requires urgent medical assessment 1, 7
- Suspected myeloid/lymphoid neoplasms with eosinophilia should be referred to hematology 7
- Suspected eosinophilic esophagitis or gastrointestinal involvement warrants gastroenterology consultation 7, 8